Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Atossa Therapeutics's price to sales ratio was 339.6× on Jan 30, 2015, against 63.0× a year earlier. Over the last 2 years it ranged from 36.1× to 415.0×, with a median of 120.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jan 30, 2015 | 339.6× | −75.5 |
| 2014 | Dec 31, 2014 | 415.0× | +355.8 |
| 2013 | Dec 31, 2013 | 59.2× | −63.6 |
| 2012 | Dec 31, 2012 | 122.8× | – |
See a number that looks wrong?